FUNDACIÓN DE GESTIÓN SANITARIA DEL HOSPITAL DE LA SANTA CREU I SANT PAU has floated a tender for Pre-Commercial Procurement to Buy R&D (Research and Development) Services to Deliver Quick Responses for Individuals with Advanced Heart Failure and Complex Care Needs through Integrated Care (Tique). The project location is Spain and the tender is closing on 23 Jul 2022. The tender notice number is 374082-2021, while the TOT Ref Number is 55483198.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Spain
Summary : Pre-Commercial Procurement to Buy R&D (Research and Development) Services to Deliver Quick Responses for Individuals with Advanced Heart Failure and Complex Care Needs through Integrated Care (Tique)
Deadline : 23 Jul 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 55483198
Document Ref. No. : 374082-2021
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : EUR 3498969.25
Purchaser's Detail
Purchaser : FUNDACIÓN DE GESTIÓN SANITARIA DEL HOSPITAL DE LA SANTA CREU I SANT PAU Address : 167 — Pabellón Sant Antoni planta baja
Town : Barcelona
NUTS-Code : SE331 - Västerbottens län
Postal Code : 08025
Contact Point : Unidad de Contratación
Phone : +34 935537621
Fax : +34 935537631 Spain Email :contractacions@santpau.cat URL :www.santpau.cat
Tender Details
Document Type : Prior information notice without call for competition
Title : Pre-Commercial Procurement to Buy R&D (Research and Development) Services to Deliver Quick Responses for Individuals with Advanced Heart Failure and Complex Care Needs Through Integrated Care (TIQUE)
Reference Number : 2021/S 141-374082
Contract Type : Services
Estimated Value : 3498969.25 - EUR
Description : This PIN provides early information about the expected starting date and purchase volume for a pre-commercial procurement (PCP) and about the open market consultation (OMC) that is organised in preparation of this procurement. See sections II.2.4) and II.2.14) for details.
The procurement aims to trigger new solutions to be developed and tested to address the following challenge: improve treatment for patients with advanced heart failure and complex care needs through technology enabled integrated care solutions.
The main target improvements are:
• 33 % increase of patient life expectancy;
• 40 % reduction of acute hospital admission;
• 20 % reduction of drug-related health problems;
• 20 % increase of home care attention; and
• 10 % increase of end-of-life care at home.
This PCP procurement is a joint procurement by different procurers across Europe that are all facing the same common challenge and are thus looking for similar solutions (so-called ‘buyers group-).
73100000 - Research and experimental development services